EP3007695
SAMSETNINGAR OG AÐFERÐIR TIL MEÐFERÐAR VIÐ BLÓÐLEYSI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.6.2014EP published:
7.2.2024EP application number:
14811317.8
EP translation filed:
28.2.2024Grant published:
15.4.2024EPO information:
European Patent Register
Max expiry date:
3.6.2034Expiry date:
3.6.2026Next due date:
30.6.2026
Title in English:
COMPOSITIONS AND METHODS FOR TREATING ANEMIALanguage of the patent:
English
Timeline
Today
4.6.2014EP application
7.2.2024EP Publication
28.2.2024Translation submitted
15.4.2024Registration published
3.6.2026Expires
Owner
Name:
Akebia Therapeutics, Inc.Address:
245 First Street, Suite 1100, Cambridge, MA 02142, US
Inventor
Name:
SHALWITZ, RobertAddress:
Bexley, OH 43209, US
Name:
HARTMAN, CharlotteAddress:
Carmel, IN 46032, US
Name:
BUCH, AkshayAddress:
West Chester, OH 45069, US
Name:
SHALWITZ, IsaiahAddress:
Columbus, OH 43215, US
Name:
JANUSZ, JohnAddress:
West Chester, OH 45069, US
Name:
GARDNER, JosephAddress:
Cincinnati, OH 45247, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201361834808 PDate:
13.6.2013Country:
US
Number:
201361889478 PDate:
10.10.2013Country:
US
Number:
201361898885 PDate:
1.11.2013Country:
US
Number:
201361898890 PDate:
1.11.2013Country:
US
Number:
201361912185 PDate:
5.12.2013Country:
US
Supplementary protection
SPC number:
SPC470
Classification
Categories:
A61K 31/4439, A61K 31/345, A01N 43/40, A61P 7/06, A61P 43/00, A61K 31/44, A61K 31/4412, A61P 13/12
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 24.5.2024
Expires: 3.6.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 10.6.2025
Expires: 3.6.2026
Payer: Árnason Faktor ehf.